2007Acta Academiae Medicinae WannanRequires access

Central intrathoracic venous catheter for draining malignant pleural fluid

Wang Lu

Open publisher page 0 citations

Abstract

Objective:To evaluate the clinical efficacy of central intrathoracic venous catheter for drainage and administration of sclerosing agent in treatment of malignant transformation pleural fluid.Methods: Thirty-five patients with malignant pleural effusion were applied with central venous catheters made by Arrow Company.All patients received the closed thoracic drainage and then,were treated by intracavity injection of IL-2 2~3 ×106 IU with a duration of treatment once a week for a consecutive two to four weeks.The therapeutic effects and adverse reactions were observed within month after the treatment.Results: 13 patients got complete recovery,14 partial recovery and 8 no response.The overall effective rate for the treatment was 77.1%(27/35).Conclusion: After draining pleural fluid completely,intracavity injection of IL-2 seems to be effective in treating malignant transformation pleural effusion.

About this research paper

What this paper is about

Objective:To evaluate the clinical efficacy of central intrathoracic venous catheter for drainage and administration of sclerosing agent in treatment of malignant transformation pleural fluid.Methods: Thirty-five patients with malignant pleural effusion were applied with central venous catheters made by Arrow Company.All patients received the closed thoracic drainage and then,were treated by intracavity injection of IL-2 2~3 ×106 IU with a duration of treatment once a week for a consecutive two to four weeks.The therapeutic effects and adverse reactions were observed within month after the treatment.Results: 13 patients got complete recovery,14 partial recovery and 8 no response.The overall effective rate for the treatment was 77.1%(27/35).Conclusion: After draining pleural fluid completely,intracavity injection of IL-2 seems to be effective in treating malignant transformation pleural effusion.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluate the clinical efficacy of central intrathoracic venous catheter for drainage and administration of sclerosing agent in treatment of malignant transformation pleural fluid.Methods: Thirty-five patients with malignant pleural effusion were applied with central venous catheters made by Arrow Company.All patients received the closed thoracic drainage and then,were treated by intracavity injection of IL-2 2~3 ×106 IU with a duration of treatment once a week for a consecutive two to four weeks.The therapeutic effects and adverse reactions were observed within month after the treatment.Results: 13 patients got complete recovery,14 partial recovery and 8 no response.The overall effective rate for the treatment was 77.1%(27/35).Conclusion: After draining pleural fluid completely,intracavity injection of IL-2 seems to be effective in treating malignant transformation pleural effusion.

Key concepts: Medicine, Malignant pleural effusion, Surgery, Catheter, Central venous catheter, Pleural effusion, Pleural fluid, Effusion

Related papers

Back to paper searchBrowse research topicsOriginal source
Central intrathoracic venous catheter for draining malignant pleural fluid — Research Paper | ScholarLens